Healthcare -
Biotechnology - NASDAQ - US
$ 0.347
-2.03 %
$ 21.5 M
Market Cap
-0.4
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Cognition Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 54 M |
| Operating Income | -54 M |
| Other Expenses | -20 M |
| Net Income | -34 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|---|
| REVENUE | ||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||
| Cost Of Revenue | 0 | 0.3 | 0.2 | 93 K | 98 K | 81 K |
| Gross Profit | 0 | (0.3) | (0.2) | 93 K | 98 K | 81 K |
| OPERATING INCOME | ||||||
| Operating Expenses | 54.0 | 50.7 | 21.3 | 11.2 | 6.6 | 4.7 |
| Selling, General and Administrative Expenses | 12.3 | 13.5 | 13.2 | 10.0 | 4.5 | 3.5 |
| Research and Development Expenses | 41.7 | 37.2 | 30.3 | 18.6 | 12.9 | 14.4 |
| Operating Income | (54.0) | (50.7) | (43.6) | (28.6) | (17.4) | (17.8) |
| PRE-TAX INCOME | ||||||
| Interest Income Expense | 25 K | 0 | 28 K | 0.9 | 1.8 | 1.0 |
| Total Other Income | 20.0 | 24.9 | 22.2 | 16.9 | 9.6 | 13.0 |
| Pre-Tax Income | (34.0) | (25.8) | (21.4) | (11.7) | (7.8) | (4.8) |
| NET INCOME | ||||||
| Tax Provision | 0 | 0 | (22.2) | (1.4) | 2.2 | 2.1 |
| Net Income | (34.0) | (25.8) | 0.8 | (10.3) | (10.1) | (7.0) |
| EPS | 0.86 | 0.86 | 0.0261 | 0.46 | 0.46 | 0.32 |